Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Post-Treatment FDG-Avid Splenic Lesions in DLBCL: Clinical and Radiographic Characteristics for Risk Assessment

Boaz Nachmias, MD PhD, Geremy Godefroy, MD, Chezi Ganzel, MD, Neta Goldschmidt, MD, Eyal Rozenbach, MD, Rachel Bar-Shalom, MD, Diana Libster, MD, Vladimir Vainstein, MD

Blood (2019) 134 (Supplement_1): 5358.

https://doi.org/10.1182/blood-2019-121473

Published: 2019

Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar

Blood (2017) 130 (Supplement 1): 2786.

https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786

Published: 2017

Journal Articles

Phase 2 Study of Abbreviated 3 Cycles of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients with Completely Excised Stage I or II CD20+ Diffuse Large B-Cell Lymphoma (CISL 12-09)

Dok Hyun Yoon, Byeong Seok Sohn, PhD, Jung Yong Hong, Sung Yong Oh, MD, Won-Sik Lee, Sang Min Lee, Deok-Hwan Yang, Jooryung Huh, Cheolwon Suh

Blood (2016) 128 (22): 4193.

https://doi.org/10.1182/blood.V128.22.4193.4193

Published: 2016

Journal Articles

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

Vikas Kumar Singh, MD, Margaret Means, Danh Pham, MD, Goetz H Kloecker, MD

Blood (2016) 128 (22): 4942.

https://doi.org/10.1182/blood.V128.22.4942.4942

Published: 2016

Journal Articles

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Danielle M. Brander, MD, Sallie D. Allgood, MS, David A. Rizzieri, MD, Tiffany Stewart, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD PhD

Blood (2014) 124 (21): 5658.

https://doi.org/10.1182/blood.V124.21.5658.5658

Published: 2014

Journal Articles

Primary Splenic Diffuse Large B-Cell Lymphoma (PS-DLBCL): Splenectomy Improves Survival

Osnat Bairey, MD, Lev Shvidel, MD, Chava Perry, MD PhD, Eldad J Dann, MD, Rosa Ruchlemer, MD, Tamar Tadmor, MD, Neta Goldschmidt, MD

Blood (2014) 124 (21): 4439.

https://doi.org/10.1182/blood.V124.21.4439.4439

Published: 2014

Journal Articles

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Ruben A. Mesa, MD, FACP, Susan Schwager, Jocelin Huang, MD, Kebede Hussein, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 5224.

https://doi.org/10.1182/blood.V112.11.5224.5224

Published: 2008

Journal Articles

Bendamustine, Rituximab and Bortezomib Combined with Liposomal Ara-C (DepoCyte ® ) for CNS Prophylaxis in Relapsed/Refractory Dlbcl: A Case Report

Fabio Ardizzone, Michele Sciacca, Paola Migliora, Cristina Ravanelli, Alberto Santagostino

Blood (2008) 112 (11): 4969.

https://doi.org/10.1182/blood.V112.11.4969.4969

Published: 2008

Journal Articles

Predictive Value of the Pre-Operative CT Scan for Splenectomy in Patients with Primary, and Post Essential Thrombocythemia/Post Polycythemia Vera Myelofibrosis.

Ruben A. Mesa, MD, Brian Bartholmai, MD, Chin Y. Li, MD, Susan Schwager, Animesh Pardanani, MD, PHD, Kebede Hussein, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 4632.

https://doi.org/10.1182/blood.V110.11.4632.4632

Published: 2007

Journal Articles

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

M. Houman Fekrazad, MD, Lizabeth Rosenbaum, M.D., Mohammad A. Vasef, M.D., Ian Rabinowitz, M.D.

Blood (2007) 110 (11): 4509.

https://doi.org/10.1182/blood.V110.11.4509.4509

Published: 2007

Journal Articles

Rescue with Rituximab ® Monotherapy in Resistant T - Cell Rich B - Cell Lymphoma (TCRBCL).

Ruben A. Burgos, MD, Isabel A. Hanono, MD, Maria C. Foncuberta, MD, Enzo Domenichini, MD, Eduardo Huertas, MD, Julio C. Sanchez Avalos, MD, Norma E. Tartas, MD

Blood (2005) 106 (11): 4762.

https://doi.org/10.1182/blood.V106.11.4762.4762

Published: 2005

Journal Articles

Palliative Splenectomy for Myelofibrosis with Myeloid Metaplasia: Three Decades of Experience in 314 Patients.

Ruben A. Mesa, MD, Susan Schwager, David S. Nagorney, MD, Ayalew Tefferi, MD

Blood (2004) 104 (11): 1510.

https://doi.org/10.1182/blood.V104.11.1510.1510

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Post-Treatment FDG-Avid Splenic Lesions in DLBCL: Clinical and Radiographic Characteristics for Risk Assessment

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Phase 2 Study of Abbreviated 3 Cycles of Rituximab Plus CHOP (Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients with Completely Excised Stage I or II CD20+ Diffuse Large B-Cell Lymphoma (CISL 12-09)

ITP or Not-ITP - a Rare Case of PTLD Recurrence Presenting As Autoimmune Thrombocytopenia

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Primary Splenic Diffuse Large B-Cell Lymphoma (PS-DLBCL): Splenectomy Improves Survival

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Bendamustine, Rituximab and Bortezomib Combined with Liposomal Ara-C (DepoCyte ® ) for CNS Prophylaxis in Relapsed/Refractory Dlbcl: A Case Report

Predictive Value of the Pre-Operative CT Scan for Splenectomy in Patients with Primary, and Post Essential Thrombocythemia/Post Polycythemia Vera Myelofibrosis.

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

Rescue with Rituximab ® Monotherapy in Resistant T - Cell Rich B - Cell Lymphoma (TCRBCL).

Palliative Splenectomy for Myelofibrosis with Myeloid Metaplasia: Three Decades of Experience in 314 Patients.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only